Orforglipron + Ritonavir Interaction
Majorinteraction on record
Description
Strong CYP3A4 inhibitor that also inhibits OATP1B; avoid concomitant use as it significantly increases FOUNDAYO plasma concentrations and risk of adverse reactions.
Mechanism
CYP3A4 and OATP1B inhibition increases FOUNDAYO exposure
Source: NLP:orforglipron